Related references
Note: Only part of the references are listed.Synthetic and biological approaches to map substrate specificities of proteases
Shiyu Chen et al.
BIOLOGICAL CHEMISTRY (2020)
Caspase selective reagents for diagnosing apoptotic mechanisms
Marcin Poreba et al.
CELL DEATH AND DIFFERENTIATION (2019)
Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases
Jonas Hahn et al.
FASEB JOURNAL (2019)
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers
Melicent Peck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer
Seung Woo Chung et al.
BIOMATERIALS (2019)
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ
Michael S. Toss et al.
HISTOPATHOLOGY (2019)
Recent advances in the development of legumain-selective chemical probes and peptide prodrugs
Marcin Poreba
BIOLOGICAL CHEMISTRY (2019)
Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells
Marcin Poreba et al.
CELL DEATH AND DIFFERENTIATION (2019)
Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study
Herve Tilly et al.
LANCET ONCOLOGY (2019)
GENT2: an updated gene expression database for normal and tumor tissues
Seung-Jin Park et al.
BMC MEDICAL GENOMICS (2019)
Polatuzumab Vedotin: First Global Approval
Emma D. Deeks
DRUGS (2019)
Immunogenicity of antibody-drug conjugates: observations across 8 molecules in 11 clinical trials
Montserrat Carrasco-Triguero et al.
BIOANALYSIS (2019)
Leveraging Peptide Substrate Libraries to Design Inhibitors of Bacterial Lon Protease
Brett M. Babin et al.
ACS CHEMICAL BIOLOGY (2019)
Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer
Corbin Pontious et al.
PANCREATOLOGY (2019)
Pharmacokinetics of protein and peptide conjugates
Brandon Bumbaca et al.
DRUG METABOLISM AND PHARMACOKINETICS (2019)
Fluorescent probes towards selective cathepsin B detection and visualization in cancer cells and patient samples
Marcin Poreba et al.
CHEMICAL SCIENCE (2019)
Cleavable linkers in antibody-drug conjugates
Jonathan D. Bargh et al.
CHEMICAL SOCIETY REVIEWS (2019)
Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads
Joanna C. Masters et al.
INVESTIGATIONAL NEW DRUGS (2018)
Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity
BinQing Wei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2018)
On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site
Eirinaios I. Vrettos et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2018)
New photodynamic molecular beacons (PMB) as potential cancer-targeted agents in PDT
Aurelie Stallivieri et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples
Wioletta Rut et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
J. M. Connors et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The good, the bad, and the ugly - controlling singlet oxygen through design of photosensitizers and delivery systems for photodynamic therapy
Susan Callaghan et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2018)
Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes
Marcin Poreba et al.
CHEMICAL SCIENCE (2018)
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice
Yasuaki Anami et al.
NATURE COMMUNICATIONS (2018)
Matriptase-2 deficiency protects from obesity by modulating iron homeostasis
Alicia R. Folgueras et al.
NATURE COMMUNICATIONS (2018)
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
Prashant D. Tailor et al.
Oncotarget (2018)
Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease
Alexandre Denadai-Souza et al.
SCIENTIFIC REPORTS (2018)
Self-Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase-Cleavable Linker
Seung Woo Chung et al.
ADVANCED SCIENCE (2018)
Cyclopeptidic photosensitizer prodrugs as proteolytically triggered drug delivery systems of pheophorbide A: part I - self-quenched prodrugs
Jordan Bouilloux et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2018)
Protease Specificity: Towards In Vivo Imaging Applications and Biomarker Discovery
Matej Vizovisek et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model
Joseph Flores et al.
NATURE COMMUNICATIONS (2018)
Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
Hirobumi Fuchigami et al.
SCIENTIFIC REPORTS (2018)
Emerging challenges in the design of selective substrates, inhibitors and activity-based probes for indistinguishable proteases
Paulina Kasperkiewicz et al.
FEBS JOURNAL (2017)
Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer
Xiao-Mei Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Toolbox of Fluorescent Probes for Parallel Imaging Reveals Uneven Location of Serine Proteases in Neutrophils
Paulina Kasperkiewicz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise
Hui Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity
Marcin Poreba et al.
NATURE PROTOCOLS (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Antibody-Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections
Sanjeev Mariathasan et al.
TRENDS IN MOLECULAR MEDICINE (2017)
The Future of Cysteine Cathepsins in Disease Management
Lovro Kramer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation
Sang-Seok Oh et al.
CELL DEATH & DISEASE (2017)
ADME and Safety Aspects of Non-cleavable Linkers in Drug Discovery and Development
M. Walles et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families
Marcin Poreba et al.
SCIENTIFIC REPORTS (2017)
Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains
I-Ju Chen et al.
SCIENTIFIC REPORTS (2017)
Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates
Nina G. Caculitan et al.
CANCER RESEARCH (2017)
Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody-Drug Conjugates
Alberto Dal Corso et al.
BIOCONJUGATE CHEMISTRY (2017)
Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy
Chengyuan Zhang et al.
ACTA BIOMATERIALIA (2017)
Peptidomimetic therapeutics: scientific approaches and opportunities
Nir Qvit et al.
DRUG DISCOVERY TODAY (2017)
Peptide-drug conjugates as effective prodrug strategies for targeted delivery
Yin Wang et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Tumor penetrating peptides for improved drug delivery
Erkki Ruoslahti
ADVANCED DRUG DELIVERY REVIEWS (2017)
Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis
Benjamin Bian et al.
MOLECULAR CARCINOGENESIS (2016)
Current trends and challenges in proteomic identification of protease substrates
Matej Vizovisek et al.
BIOCHIMIE (2016)
In vivo imaging of protease activity by Probody therapeutic activation
Kenneth R. Wong et al.
BIOCHIMIE (2016)
Antibody-drug conjugates-an emerging class of cancer treatment
Nikolaos Diamantis et al.
BRITISH JOURNAL OF CANCER (2016)
Cacidases: caspases can cleave after aspartate, glutamate and phosphoserine residues
J. E. Seaman et al.
CELL DEATH AND DIFFERENTIATION (2016)
Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease
Xia Chen et al.
CELL RESEARCH (2016)
The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria
Hao Li et al.
FEBS JOURNAL (2016)
Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer
Leila Akkari et al.
GENES & DEVELOPMENT (2016)
Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB antibody antibiotic conjugate against Staphylococcus aureus in mice
Chenguang Zhou et al.
MABS (2016)
Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
Heather Donaghy
MABS (2016)
Identification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative Proteomics
Martin L. Biniossek et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
Magdalena Dorywalska et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Synthesis and Preclinical Evaluation of a Highly Improved Anticancer Prodrug Activated by Histone Deacetylases and Cathepsin L
Nobuhide Ueki et al.
THERANOSTICS (2016)
High levels of cathepsin D and cystatin B are associated with increased risk of coronary events
Isabel Goncalves et al.
OPEN HEART (2016)
Lysosomal Cathepsin A Plays a Significant Role in the Processing of Endogenous Bioactive Peptides
Zehra Keyser Timur et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2016)
Cathepsin L is involved in proliferation and invasion of breast cancer cells
G. Qin et al.
NEOPLASMA (2016)
A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application
Megan Garland et al.
CELL CHEMICAL BIOLOGY (2016)
Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes
Marcin Poreba et al.
CELL CHEMICAL BIOLOGY (2016)
Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery
Hong Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo
Shi-Ying Li et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates
Magdalena Dorywalska et al.
BIOCONJUGATE CHEMISTRY (2015)
Synthesis and Evaluation of a CBZ-AAN-Dox Prodrug and its in vitro Effects on SiHa Cervical Cancer Cells Under Hypoxic Conditions
Hongyuan Chen et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Small Molecule Active Site Directed Tools for Studying Human Caspases
Marcin Poreba et al.
CHEMICAL REVIEWS (2015)
The protease cathepsin L regulates Th17 cell differentiation
Lifei Hou et al.
JOURNAL OF AUTOIMMUNITY (2015)
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Maria Corinna A. Palanca-Wessels et al.
LANCET ONCOLOGY (2015)
Moving targets: Emerging roles for MMPs in cancer progression and metastasis
Gemma Shay et al.
MATRIX BIOLOGY (2015)
Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells
Barbara Sobotic et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki et al.
NATURE (2015)
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Sophie M. Lehar et al.
NATURE (2015)
Current ADC Linker Chemistry
Nareshkumar Jain et al.
PHARMACEUTICAL RESEARCH (2015)
A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
Rajendra Raut et al.
VIROLOGY JOURNAL (2015)
Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
Masami Suzuki et al.
Journal of Toxicologic Pathology (2015)
Enzyme-Specific Doxorubicin Drug Beacon as Drug-Resistant Theranostic Molecular Probes
Lye Lin Lock et al.
ACS MACRO LETTERS (2015)
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Oakley C. Olson et al.
NATURE REVIEWS CANCER (2015)
Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
Yu-Tzu Tai et al.
BLOOD (2014)
Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates
Marcin Poreba et al.
CELL DEATH AND DIFFERENTIATION (2014)
Pericellular proteolysis in cancer
Lisa Sevenich et al.
GENES & DEVELOPMENT (2014)
Phagocytosis of Staphylococcus aureus by Human Neutrophils Prevents Macrophage Efferocytosis and Induces Programmed Necrosis
Mallary C. Greenlee-Wacker et al.
JOURNAL OF IMMUNOLOGY (2014)
Targeted Theranostic Platinum(IV) Prodrug with a Built-In Aggregation-Induced Emission Light-Up Apoptosis Sensor for Noninvasive Early Evaluation of Its Therapeutic Responses in Situ
Youyong Yuan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Tumor-Targeted Prodrug ICT2588 Demonstrates Therapeutic Activity against Solid Tumors and Reduced Potential for Cardiovascular Toxicity
Jason H. Gill et al.
MOLECULAR PHARMACEUTICS (2014)
Tofacitinib versus Methotrexate in Rheumatoid Arthritis
Eun Bong Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
Christina Hagglof et al.
PLOS ONE (2014)
Design of ultrasensitive probes for human neutrophil elastase through hybrid combinatorial substrate library profiling
Paulina Kasperkiewicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Basis for substrate recognition and distinction by matrix metalloproteinases
Boris I. Ratnikov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cathepsin B: Multiple roles in cancer
Neha Aggarwal et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation
Meilang Xue et al.
RHEUMATOLOGY (2014)
Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin
B-x Yan et al.
CELL DEATH & DISEASE (2014)
An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability
Hong-Bo Pang et al.
NATURE COMMUNICATIONS (2014)
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
Christine Mehner et al.
ONCOTARGET (2014)
Cathepsin B as a cancer target
Christopher S. Gondi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)
Yan-Jun Zhong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease
Gustavo Basurto-Islas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Effect of posttranslational modifications on enzyme function and assembly
Helena Ryslava et al.
JOURNAL OF PROTEOMICS (2013)
Imaging a functional tumorigenic biomarker in the transformed epithelium
Aaron M. LeBeau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety
Lin Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation
Elfriede Dall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease
Nobuhide Ueki et al.
NATURE COMMUNICATIONS (2013)
Targeting Cathepsin E in Pancreatic Cancer by a Small Molecule Allows In Vivo Detection
Edmund J. Keliher et al.
NEOPLASIA (2013)
Cysteine cathepsins: From structure, function and regulation to new frontiers
Vito Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Cardiac Inflammation after Local Irradiation Is Influenced by the Kallikrein-Kinin System
Vijayalakshmi Sridharan et al.
CANCER RESEARCH (2012)
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Anas Younes et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Enhanced Prostate Cancer Targeting by Modified Protease Sensitive Photosensitizer Prodrugs
Maria-Fernanda Zuluaga et al.
MOLECULAR PHARMACEUTICS (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben-Quan Shen et al.
NATURE BIOTECHNOLOGY (2012)
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
Niagara Muhammad Idris et al.
NATURE MEDICINE (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Protease-Activated Drug Development
Ki Young Choi et al.
THERANOSTICS (2012)
Novel diagnostic biomarkers for prostate cancer
Chikezie O. Madu et al.
Journal of Cancer (2012)
Prodrugs for improving tumor targetability and efficiency
Rubi Mahato et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
The Legumain Protease-Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity
Krishna Mohan Bajjuri et al.
CHEMMEDCHEM (2011)
A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis
Sarah L. Tressel et al.
EMBO MOLECULAR MEDICINE (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
MMP-2 Mediates Angiotensin II-Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE
Jeffrey Odenbach et al.
HYPERTENSION (2011)
Tumor Targeting of MMP-2/9 Activatable Cell-Penetrating Imaging Probes Is Caused by Tumor-Independent Activation
Sander M. J. van Duijnhoven et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Multiplex Zymography Captures Stage-specific Activity Profiles of Cathepsins K, L, and S in Human Breast, Lung, and Cervical Cancer
Binbin Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds
Doris Gabriel et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2011)
Novel tumor-targeted RGD peptide-camptothecin conjugates: Synthesis and biological evaluation
Alma Dal Pozzo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases
Jennifer M. Atkinson et al.
CANCER RESEARCH (2010)
Activatable Photosensitizers for Imaging and Therapy
Jonathan F. Lovell et al.
CHEMICAL REVIEWS (2010)
Current Strategies for Probing Substrate Specificity of Proteases
M. Poreba et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Emerging principles in protease-based drug discovery
Marcin Drag et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Kazuki N. Sugahara et al.
SCIENCE (2010)
Extracellular Matrix Proteins and Tumor Angiogenesis
N. E. Campbell et al.
JOURNAL OF ONCOLOGY (2010)
A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain
Liron Stern et al.
BIOCONJUGATE CHEMISTRY (2009)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Type II Transmembrane Serine Proteases
Thomas H. Bugge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Thrombin-sensitive photodynamic agents: A novel strategy for selective synovectomy in rheumatoid arthritis
Doris Gabriel et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Photodynamic Molecular Beacon Triggered by Fibroblast Activation Protein on Cancer-Associated Fibroblasts for Diagnosis and Treatment of Epithelial Cancers
Pui-Chi Lo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin αvβ3
Claudia Ryppa et al.
BIOCONJUGATE CHEMISTRY (2008)
A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy
Yoshiyuki Yoneda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
Detection of early prostate cancer using a hepsin-targeted imaging agent
Kimberly A. Kelly et al.
CANCER RESEARCH (2008)
Peptidomimetics, a synthetic tool of drug discovery
Josef Vagner et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis
Garth Hamilton et al.
EMBO JOURNAL (2008)
Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer
Zheng-Sheng Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Proteases: Multifunctional Enzymes in Life and Disease
Carlos Lopez-Otin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer
Yu Cheng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Aliskiren: the first renin inhibitor for clinical treatment
Chris Jensen et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer
J. Decock et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2008)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A prostate-specific antigen-activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer
Sachin S. Chandran et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Tumour micro environment -: Opinion -: Emerging roles of proteases in tumour suppression
Carlos LOpez-Otin et al.
NATURE REVIEWS CANCER (2007)
Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase
Flavia L. Ribeiro-Gomes et al.
JOURNAL OF IMMUNOLOGY (2007)
Synthesis, cleavage profile, and antitumor efficacy of an albumin-binding prodrug of methotrexate that is cleaved by plasmin and cathepsin B
Andre Warnecke et al.
ARCHIV DER PHARMAZIE (2007)
Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes
Doris Gabriel et al.
BIOCONJUGATE CHEMISTRY (2007)
Polymeric photosensitizer prodrugs for photodynamic therapy
Marino A. Campo et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2007)
Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation
Gang Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Albumin-binding prodrugs of camptothecin and doxorubicin with an ala-leu-ala-leu-linker that are cleaved by cathepsin B: Synthesis and antitumor efficacy
Bjoern Schmid et al.
BIOCONJUGATE CHEMISTRY (2007)
Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery
Eric P. Holowka et al.
NATURE MATERIALS (2007)
Matriptase and its putative role in cancer
K. Uhland
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)
Da-Eun Chung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Selective antitumor effect of novel protease-mediated photodynamic agent
Yongdoo Choi et al.
CANCER RESEARCH (2006)
Water-soluble HPMA copolymer -: prostaglandin E1 conjugates containing a cathepsin K sensitive spacer
Huaizhong Pan et al.
JOURNAL OF DRUG TARGETING (2006)
Sitagliptin: A dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Shannon A. Miller et al.
ANNALS OF PHARMACOTHERAPY (2006)
Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ
Klara Stefflova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities
Y Choe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrix metalloproteinases (MMPs) in health and disease: an overview
CJ Malemud
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors
B Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression
IA Khalil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms
WY Wu et al.
CANCER RESEARCH (2006)
Dipeptide-based highly potent doxorubicin antibody conjugates
SC Jeffrey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation
K List et al.
GENES & DEVELOPMENT (2005)
Cutaneous adverse effects with HER1/EGFR-targeted agents:: Is there a silver lining?
R Peréz-Soler et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery
XY Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
JA Joyce et al.
CANCER CELL (2004)
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
G La Rocca et al.
BRITISH JOURNAL OF CANCER (2004)
Review - Proteases, extracellular matrix, and cancer - A workshop of the path B study section
YA DeClerck et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies
JF DiJoseph et al.
BLOOD (2004)
Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation
J Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates
CL Law et al.
CLINICAL CANCER RESEARCH (2004)
Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites
PS Sijwali et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Membrane associated proteases and their inhibitors in tumour angiogenesis
A Noel et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Development of the proteasome inhihitor Veleade((TM)) (Bortezomib)
J Adams et al.
CANCER INVESTIGATION (2004)
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
JA Francisco et al.
BLOOD (2003)
Extracellular matrix remodelling: the role of matrix metalloproteinases
I Stamenkovic
JOURNAL OF PATHOLOGY (2003)
Human and mouse proteases:: A comparative genomic approach
XS Puente et al.
NATURE REVIEWS GENETICS (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human and parasitic papain-like cysteine proteases:: Their role in physiology and pathology and recent developments in inhibitor design
F Lecaille et al.
CHEMICAL REVIEWS (2002)
Serine protease mechanism and specificity
L Hedstrom
CHEMICAL REVIEWS (2002)
Structure and mechanism of the pepsin-like family of aspartic peptidases
BM Dunn
CHEMICAL REVIEWS (2002)
Thrombin functions during tissue factor-induced blood coagulation
KE Brummel et al.
BLOOD (2002)
Cathepsin B-labile dipeptide linkers for lysosomal release of doxorubicin from internalizing immunoconjugates: Model studies of enzymatic drug release and antigen-specific in vitro anticancer activity
GM Dubowchik et al.
BIOCONJUGATE CHEMISTRY (2002)
Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries
MA Mathieu et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: A novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect
M Kovar et al.
BIOCONJUGATE CHEMISTRY (2002)
Cleavable linkers to enhance selectivity of antibody-targeted therapy of cancer
DL Kukis et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse
EL Sievers et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Expression of invariant chain and pro-cathepsin L in Alzheimer's brain
Y Yoshiyama et al.
NEUROSCIENCE LETTERS (2000)
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure
WC Wolf et al.
KIDNEY INTERNATIONAL (2000)
Fluorescent microplate assay for cancer cell-associated cathepsin B
KI Hulkower et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis
TT Lah et al.
HUMAN PATHOLOGY (2000)
Share Paper
